RxDoctor Payments Data

Dalice Roberson

Physician Assistant · Corbin, KYNPI 1508336389

Payments from drug & device makers

$1,373in general payments, 2019–2025

Across 89 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$207
  • Pfizer$188
  • AbbVie$174
  • AstraZeneca$174
  • Merck$126
  • Novartis$120
  • plus $384 from 13 others

What the payments were for

  • Food & beverage$1,373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,373 in reported general payments places this provider in the 70th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,597
Medicare patients
45
Services billed
117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide67$78,249
OzempicSemaglutide49$48,833
EliquisApixaban34$24,866
JanuviaSitagliptin Phosphate27$24,172
TrulicityDulaglutide16$20,781
FarxigaDapagliflozin Propanediol16$16,631
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$14,601
MyrbetriqMirabegron19$13,397
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,247
Repatha SureclickEvolocumab12$8,827
Tresiba Flextouch U-100Insulin Degludec12$7,559
SymbicortBudesonide/Formoterol Fumarate23$7,414
VascepaIcosapent Ethyl12$6,202
Humalog Kwikpen U-100Insulin Lispro20$6,068
ShingrixVaricella-Zoster Ge/As01b/Pf18$3,609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$207$99,02983 claims
Novo NordiskOzempic$48$48,83349 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$174$33,29254 claims
PfizerEliquis$188$24,86634 claims
MerckJanuvia$126$24,17227 claims
GSKShingrix$15$3,60918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →